Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on April 15, 2025

Polymer Medical adds contract packager James Alexander Corp. to customer line-up
Polymer Medical and James Alexander Corp. initially signed a contract in 2024 with the work now increasing the production of single-use plastic ampoules. ORCHARD PARK, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Polymer Medical has ramped up …

D.A.W. Systems Appoints John Ketcham as Chief Revenue Officer to Accelerate Growth and Expansion
ALBANY, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- D.A.W. Systems, Inc. (www.dawsystems.com), developer of the ScriptSure E-Prescribing, announces the appointment of John Ketcham as its new Chief Revenue Officer (CRO). In this role, Ketcham …

Salve Strengthens North American Presence with Strategic Expansion to Support Fertility Market
NEW YORK, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Salve; a digital health platform specializing in delivering a world class digital experience for patients going through fertility treatments, helping patients and clinics alike to make the …

Patients Medical Expands Functional IV Therapy Services in NYC. Supports Immune Health, Fatigue, and Nutrient Deficiency
The expanded offerings now include personalized vitamin IV drips, nutrient IV therapy, and advanced NAD+ and glutathione infusions, under physicians care. NEW YORK, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Patients Medical Expands …

The Brookbush Institute Publishes NEW Glossary Updates: 'Plyometric and Amortization Phase'
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- Excerpt from the glossary term: Plyometric - …

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or …

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
MELBOURNE, Australia and INDIANAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in …

World Parkinson Coalition® Announces Parkinson’s Red Thread Project
A visual art exhibit at the 7th World Parkinson Congress uniting the global Parkinson’s community NEW YORK, NY, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- To celebrate the strength, resiliency and the incredible relationships within the …

Fatima Rifai Expands Functional Diet Supplement Business Amid Lebanon’s Economic Crisis
Photo Courtesy of Diet By Tam BEIRUT, Lebanon, April 15, 2025 (GLOBE NEWSWIRE) -- Diet by Tam, a health and wellness company based in Beirut, has announced the expansion of its functional supplement range with the introduction of five new products. The …

Theratechnologies Provides Update on Sale Process
MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current …

Theratechnologies fait le point sur le processus de vente
MONTRÉAL, 15 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui qu’après un examen attentif des circonstances …

Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the first patient in China has been dosed in the …

Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care
CEDAR PARK, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Ascension Seton is deepening its commitment to patient-centered care in Central Texas by acquiring full ownership of Cedar Park Medical Center. This transition marks a significant step in Ascension …

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonardo Viana Nicacio, M …

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
Reports expansion of CompuFlo® Epidural System across additional pain management clinics and ambulatory surgery centers following Medicare price assignment in multiple U.S. states ROSELAND, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific …

Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …

Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …

Healthcare Integrated Technologies Inc. Appoints Sasidhar Valluru as Director of Global Product Delivery
Mr. Valluru Joins to Strengthen HITC’s Global Technology Operations Knoxville, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces …